Profile: Pfizer Inc (PFE)
27 May 2015
Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a bio pharmaceutical company. The company applies science and resources to discover, develop and manufacture healthcare products. The Company provides medicines, vaccines and consumer healthcare products. The Company operates its business through three operating segments, which include Global Innovative Pharmaceutical segment (GIP); the Global Vaccines, Oncology and Consumer Healthcare segment (VOC), and the Global Established Pharmaceutical segment (GEP).
The Company provides medical information to healthcare providers, patients and other parties, transparency and disclosure activities, clinical trial results publication, grants for healthcare quality improvement and medical education, partnerships with global public health and medical associations, regulatory inspection readiness reviews, internal audits of Pfizer-sponsored clinical trials and internal regulatory compliance processes. The Company’s products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, BeneFIX, Vfend, Pristiq, Genotropin, Refacto AF/Xyntha, Chantix/Champix, Xalatan/Xalacom, Medrol, Zoloft, Xalkori, Inlyta, Relpax, Rapamune and the Premarin family of products, among others. Global Innovative Pharmaceutical segment Global Innovative Pharmaceutical segment (GIP) consists of medicines in a range of therapeutic areas. These therapeutic areas include immunology and inflammation, cardiovascular or metabolic, neuroscience and pain, rare diseases and women's or men's health. Global Vaccines, Oncology and Consumer Healthcare segment Global Vaccines, Oncology and Consumer Healthcare segment (VOC) focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. The VOC segment also includes its global Consumer Healthcare business, which manufactures and markets a range of over-the-counter (OTC) products. Global Established Pharmaceutical segment Global Established Pharmaceutical segment (GEP) includes the brands that have patent-protected products and generic pharmaceuticals. GEP includes the Company’s sterile injectable products and biosimilar development portfolio.
235 E 42ND ST
NEW YORK NY 10017-5703
Company Web Links
- BRIEF-Viiv Healthcare says Aurobindo Pharma applies for FDA approval for HIV treatment
- ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV
- RPT-INSIGHT-Fight over hot new cholesterol drugs may be won in milligrams
- U.S. health group PureTech seeks $160 million in London listing
- U.S. health group PureTech seeks $160 mln in London listing